Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,041 shares at $70.53 ($73K) on 2016-04-20, disclosed to the SEC on 2016-04-21.
Scheduled sale ($73k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.86 | 392 | $27K | 37.4% |
| 2 | $70.53 | 649 | $46K | 62.6% |
| Total | $70.28 avg | 1,041 | $73K | 100% |
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |